InnovAge Holding (InnovAge Holding) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of InnovAge Holding is: No Data: Cannot be evaluated.

Competitive Comparison of InnovAge Holding's Risk Assessment

For the Medical Care Facilities subindustry, InnovAge Holding's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnovAge Holding's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Risk Assessment distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's Risk Assessment falls into.

InnovAge Holding (NAS:INNV) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

InnovAge Holding Risk Assessment Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

InnovAge Holding (InnovAge Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

8950 East Lowry Boulevard, Denver, CO, USA, 80230

Website

https://www.innovage.com

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

Executives

Teresa Sparks	director	40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Nicole Damato	officer: CHIEF LEGAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Benjamin C Adams	officer: CHIEF FINANCIAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent	officer: CHIEF OPERATIONS OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully	director	320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer	officer: CHIEF MEDICAL OFFICER	C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair	officer: PRESIDENT	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert	director	580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh	director	601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt	director, officer: CEO, President and Director	8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano	officer: CORPORATE COO	8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr	officer: CHIEF SALES AND MKTG. OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch	officer: CHIEF MEDICAL OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230